Estonia to develop personalized CAR T-cell therapy for blood cancer patients

Owen Witte awarded International Harrington Prize for Innovation in Medicine

The Harrington Discovery Institute at University Hospitals and the American Society for Clinical Investigation have awarded Owen Witte with the twelfth annual Harrington Prize for Innovation in Medicine.

March 21, 2025

Vol.51 No.11

In Brief

Nemours opens Lisa Dean Moseley Foundation Institute for Cancer and Blood Disorders

Nemours Children’s Health opened the Lisa Dean Moseley Foundation Institute for Cancer and Blood Disorders, on March 19. The institute is a state-of-the-art facility for pediatric patients in the Delaware Valley and beyond.

March 21, 2025

Vol.51 No.11

In Brief

Megan Melody joins cellular therapies program at Tampa General Hospital

Megan Melody joined the Tampa General Hospital Cancer Institute Cellular Therapy team. She was formerly at the McGaw Medical Center of Northwestern University.

March 07, 2025

Vol.51 No.09

Clinical Roundup

CAR T-cell therapy for B-ALL results in high incidence of durable response in phase I/II study

B-cell acute lymphoblastic leukemia is a common type of ALL in adults.

March 07, 2025

Vol.51 No.09

Guest Editorial

The fight against cancer is global. Our focus must be as well.

Today, our world is small. It feels smaller all the time. In a few hours we can get to any point on the globe.

February 21, 2025

Vol.51 No.07

By W. Kimryn Rathmell

Clinical Roundup

CAR T therapy shows durable responses in large B-cell lymphoma

Allogene Therapeutics Inc. announced the publication of data from its phase I ALPHA and ALPHA2 clinical studies of cemacabtagene ansegedleucel (cema-cel; formerly ALLO-501/A) in relapsed/refractory large B-cell lymphoma as a rapid communication in the Journal of Clinical Oncology.